{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:30:11Z","timestamp":1790289011538,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020898","name":"UFCSPA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020898","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ygyno.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T12:31:41Z","timestamp":1736598701000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study"],"prefix":"10.1016","volume":"193","author":[{"given":"Elza Maria Hartmann","family":"Uberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia Rosi","family":"de Freitas Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Bernardes","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine Paiva","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassiano Burman","family":"Patias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Feiten","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosilene Jara","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josenel Maria Barcelos","family":"Mar\u00e7al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2025.01.003_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2025.01.003_bb0010","series-title":"Gynecologic Oncology Handbook. An Evidence-Based Clinical Guide","first-page":"234","author":"Benoit","year":"2023"},{"key":"10.1016\/j.ygyno.2025.01.003_bb0015","unstructured":"Horowitz NS, Elias KM, Berkowitz R. Presentation and Management of Gestational Trophoblastic Neoplasia in the USA. (2022) [Cited August 3, 2024] Available in: https:\/\/isstd.org\/uploadedfiles\/10pstt-ett.pdf."},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2025.01.003_bb0020","first-page":"241","article-title":"Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since international FIGO 2000 consensus","volume":"59","author":"Braga","year":"2014","journal-title":"J. Reprod. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2025.01.003_bb0025","first-page":"634","article-title":"Management of complete molar pregnancy","volume":"32","author":"Berkowitz","year":"1987","journal-title":"J. Reprod. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2025.01.003_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000536494","article-title":"The rare of the rarest: placental site trophoblastic tumor, epithelioid trophoblastic tumor, atypical placental site nodule","volume":"89","author":"Marquina","year":"2024","journal-title":"Gynecol. Obstet. Investig."},{"issue":"4","key":"10.1016\/j.ygyno.2025.01.003_bb0035","first-page":"475","article-title":"Prevention of gestational trophoblastic disease by use of actinomycin D in molar pregnancies","volume":"43","author":"Goldstein","year":"1974","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.01.003_bb0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1097-0142(19860801)58:3<624::AID-CNCR2820580305>3.0.CO;2-6","article-title":"Prophylactic chemotherapy for hydatidiform mole. Five to 15 years follow-up","volume":"58","author":"Kashimura","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.01.003_bb0045","unstructured":"Elias KM, Horowitz NS, Berkowitz R. Presentation and Management of Molar Pregnancy (2022) [Cited August 3, 2024]. Available in: https:\/\/isstd.org\/uploadedfiles\/8pstt-ett.pdf."},{"issue":"2","key":"10.1016\/j.ygyno.2025.01.003_bb0050","first-page":"157","article-title":"Prophylactic chemotherapy of complete molar pregnancy","volume":"22","author":"Goldstein","year":"1995","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.01.003_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1586\/14737140.3.1.48","article-title":"Chemotherapy for trophoblastic disease: current standards","volume":"3","author":"Kendall","year":"2003","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"11","key":"10.1016\/j.ygyno.2025.01.003_bb0060","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1517\/14656566.4.11.2005","article-title":"Pharmacotherapy of gestational trophoblastic disease","volume":"4","author":"Lurain","year":"2003","journal-title":"Expert. Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.ygyno.2025.01.003_bb0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2009.09.012","article-title":"Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy","volume":"115","author":"Uberti","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.01.003_bb0070","first-page":"1420","article-title":"Time to stop offering prophylactic chemotherapy after molar pregnancies?","volume":"121","author":"Seckl","year":"2014","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ygyno.2025.01.003_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2009.04.006","volume":"114","author":"Uberti","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2025.01.003_bb0080","article-title":"Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia","author":"Wang","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2025.01.003_bb0085","unstructured":"Cagayan MSFS. A Critical Appraisal of Chemopreventive Strategies Against Gestational Trophoblastic Neoplasia. Handcock BW, Seckel MJ, Berkowitz RE. (2022) [Cited August 3, 2024]. Available in: https:\/\/isstd.org\/uploadedfiles\/15%20pstt-ett.pdf ."},{"issue":"5\u20136","key":"10.1016\/j.ygyno.2025.01.003_bb0090","first-page":"225","article-title":"Molar pregnancy in adolescents","volume":"57","author":"Braga","year":"2012","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2025.01.003_bb0095","series-title":"Gynecologic Cancer Controversies in Management","first-page":"555","article-title":"Management of gestational trophoblastic disease","author":"Seckl","year":"2004"},{"issue":"2","key":"10.1016\/j.ygyno.2025.01.003_bb0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2005.12.036","article-title":"Single-dose actinomycin D: efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole","volume":"102","author":"Uberti","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2025.01.003_bb0105","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting","volume":"358","author":"Hesketh","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2025.01.003_bb0110","series-title":"Ginecologia Baseada em Evid\u00eancias. S\u00e3o Paulo","first-page":"371","article-title":"Doen\u00e7a trofobl\u00e1tica gestacional","author":"Uberti","year":"2004"},{"issue":"9","key":"10.1016\/j.ygyno.2025.01.003_bb0115","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/1097-0142(19871101)60:9<2173::AID-CNCR2820600910>3.0.CO;2-3","article-title":"Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the gynecologic oncology group","volume":"60","author":"Petrilli","year":"1987","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.01.003_bb0120","article-title":"Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia","volume":"2016","author":"Alazzam","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.ygyno.2025.01.003_bb0125","first-page":"245","article-title":"Aspectos psico-sociais da doen\u00e7a trofobl\u00e1stica gestacional: import\u00e2ncia dos \u201cGrupos de Ajuda\u201d","volume":"22","author":"Diestel","year":"2002","journal-title":"Acta Oncol. Bras."},{"issue":"4","key":"10.1016\/j.ygyno.2025.01.003_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0042-1742681","article-title":"Emotional and clinical aspects observed in women with gestational trophoblastic disease: a multidisciplinary action","volume":"44","author":"Fran\u00e7a","year":"2022","journal-title":"Bras. Ginecol. Obstet."},{"issue":"3","key":"10.1016\/j.ygyno.2025.01.003_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00003081-200309000-00005","article-title":"Sutton JM.HCG tests in the management of gestational trophoblastic diseases","volume":"346","author":"Cole","year":"2003","journal-title":"Clin. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.01.003_bb0140","first-page":"478","article-title":"Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy","volume":"58","author":"Schlaerth","year":"1981","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.01.003_bb0145","first-page":"110","article-title":"Prophylactic actinomycin D for high-risk complete hydatidiform","volume":"46","author":"Limpongsanurak","year":"2001","journal-title":"Clin. Trial J. Reprod. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2025.01.003_bb0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3349\/ymj.1996.37.6.412","article-title":"Analysis of risk factors for postmolar trophoblastic disease: categorization of risk factors and effect of prophylactic chemotherapy","volume":"37","author":"Park","year":"1996","journal-title":"Yonsel Med. J."},{"key":"10.1016\/j.ygyno.2025.01.003_bb0155","first-page":"817","article-title":"Prophylactic chemotherapy of patients with molar pregnancy","volume":"38","author":"Goldstein","year":"1971","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.01.003_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-022-02134-w","article-title":"The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ygyno.2025.01.003_bb0165","unstructured":"Parker VL, Seckl MJ, Hancock BW. Global Differences in Management and Treatment: A Critical Appraisal From a UK Perspective. Handcock BW, Seckel MJ, Berkowitz RE. [2022] [Cited August 3, 2024]. Available in: https:\/\/isstd.org\/uploadedfiles\/21pstt-ett.pdf."},{"key":"10.1016\/j.ygyno.2025.01.003_bb0170","series-title":"Trophamet Trial (Avelumab + Methotrexate). Congress ESMO","first-page":"13","author":"You","year":"2024"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:58:39Z","timestamp":1773835119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"alternative-id":["S0090825825000034"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.01.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}